LIGAND PHARMACEUTICALS INCORPORATED Other Noncash Expense
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) reported Other Noncash Expense of $31.57 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashExpense · last filed 2018-11-08
- LIGAND PHARMACEUTICALS INCORPORATED other noncash expense for the quarter ending 2018-09-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED other noncash expense for the quarter ending 2017-09-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED other noncash expense for the quarter ending 2011-12-31 was $84.00K.
- LIGAND PHARMACEUTICALS INCORPORATED other noncash expense for the quarter ending 2011-09-30 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED other noncash expense for fiscal 2014 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED other noncash expense for fiscal 2013 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED other noncash expense for fiscal 2012 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED other noncash expense for fiscal 2011 was -$51.00K, a 100.56% decline from fiscal 2010.
| Period end | Other Noncash Expense 3 month | Other Noncash Expense 6 month | Other Noncash Expense 9 month | Other Noncash Expense 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $31.57M 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | $31.57M 10-Q · filed 2018-08-08 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-08 | |||
| 2014-12-31 | $0.00 10-K · filed 2014-12-01 | |||
| 2013-12-31 | $0.00 10-K/A · filed 2014-12-12 | |||
| 2012-12-31 | $0.00 10-K/A · filed 2014-12-12 | |||
| 2011-12-31 | $84.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | $84.00K derived: sum of 2 quarters · filed 2014-12-12 | $39.00K derived: sum of 3 quarters · filed 2014-12-12 | -$51.00K 10-K/A · filed 2014-12-12 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | -$45.00K derived: sum of 2 quarters · filed 2012-11-14 | -$135.00K 10-Q · filed 2012-11-14 | -$684.00K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-06-30 | -$45.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-11-14 | -$135.00K 10-Q/A · filed 2012-11-14 | -$684.00K derived: sum of 3 quarters · filed 2013-03-14 | $8.97M derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-03-31 | -$90.00K 10-Q/A · filed 2012-11-14 | -$639.00K derived: sum of 2 quarters · filed 2013-03-14 | $9.02M derived: sum of 3 quarters · filed 2013-03-14 | |
| 2010-12-31 | -$549.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-14 | $9.11M derived: sum of 2 quarters · filed 2013-03-14 | $9.04M 10-K · filed 2013-03-14 | |
| 2010-09-30 | $9.65M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-02-10 | $9.59M 10-Q/A · filed 2012-02-10 | ||
| 2010-06-30 | -$64.00K 10-Q/A · filed 2012-02-10 | |||
| 2009-12-31 | $10.10M 10-K/A · filed 2012-11-14 |